Another subpoena and lawsuit.
Amgen Inc., the world's largest biotechnology company, received two federal subpoenas in the past month seeking documents about its products.
One subpoena came from the U.S. Attorney's Office for the Eastern District of New York on Oct. 25, and the other from the U.S. Attorney in the Western District of Washington on Nov. 1, the Thousand Oaks, California-based company disclosed in a regulatory filing on Nov. 9.
The filing doesn't say which products are involved.
The filing also says the Sheet Metal Workers National Health Fund filed a lawsuit on Nov. 2 in New Jersey alleging that Amgen's pricing ``penalizes oncology clinics'' that purchase Johnson & Johnson's anemia drug Procrit.
Amgen's anemia treatments, Aranesp and Epogen, had $6.63 billion in combined sales last year, or 46 percent of Amgen's revenue.
Source
No comments:
Post a Comment